SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT
TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): October 22, 2003
DEPOMED, INC. |
||||
(Exact name of registrant as specified in its charter) |
||||
|
|
|
|
|
California |
|
001-13111 |
|
94-3229046 |
(State of Incorporation or Organization) |
|
(Commission File Number) |
|
(I.R.S. Employer Identification No.) |
|
|
|
|
|
1360 OBrien Drive, Menlo Park, California |
|
94025 |
||
(Address of principal executive offices) |
|
(Zip Code) |
||
|
||||
Registrants telephone no., including area code: (650) 462-5900 |
||||
|
||||
NOT APPLICABLE |
||||
(Former name or former address, if changed since last report) |
Item 5. Other Events and Required FD Disclosure
On October 22, 2003, Depomed, Inc., a California corporation (the Company), entered into an Underwriting Agreement with Thomas Weisel Partners LLC, CIBC World Markets Corp. and Punk, Ziegel & Company, L.P. (together, the Underwriters) relating to the sale of 6,500,000 shares of the Companys common stock at an offering price to the public of $5.50 per share. The Underwriters have been granted a 30-day over-allotment option to purchase up to an additional 975,000 shares of common stock from the Company. The shares are being offered pursuant to the Companys Registration Statement on Form S-3, as amended (File No. 333-108973). The transaction is expected to close on October 28, 2003, subject to customary closing conditions.
The Underwriting Agreement and the press release related to the offering are attached hereto as Exhibits 1.1 and 99.1 and are incorporated by reference herein.
Item 7. Financial Statements and Exhibits.
Exhibits
|
|
1.1 |
Underwriting Agreement, dated October 22, 2003 |
|
|
99.1 |
Depomed, Inc. Press Release issued on October 23, 2003 |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
DEPOMED, INC. |
||
|
|
||
|
|
/s/ John F. Hamilton |
|
|
|
John F. Hamilton |
|
|
|
Vice
President - Finance and |
|
|
|
||
|
|
||
Date: October 23, 2003 |
|